NCT06384053View on ClinicalTrials.gov

Skin Cancer and Hyperthermia and Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2028

Conditions
Basal Cell CarcinomaSquamous Cell Carcinoma SkinNon-melanoma Skin Cancer
Interventions
COMBINATION_PRODUCT

Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined

The wIRA device applies hyperthermia by heating the treatment area (with maximum surface temperature set to 43° C), aiming to make cancer cells more sensitive to radiation therapy for non-melanoma skin cancer combined with radiotherapy.

RADIATION

Radiotherapy (RT)

Radiotherapy is applied.

Trial Locations (4)

3001

RECRUITING

Lindenhofgruppe, Bern

5001

RECRUITING

Kantonsspital Aarau, Aarau

6000

RECRUITING

Luzerner Kantonsspital, Lucerne

8401

RECRUITING

Kantonsspital Winterthur, Winterthur

All Listed Sponsors
collaborator

Luzerner Kantonsspital

OTHER

collaborator

Lindenhofgruppe AG

INDUSTRY

collaborator

Kantonsspital Aarau

OTHER

lead

Kantonsspital Winterthur KSW

OTHER